Skip to content

The Effect of a 6-month Dietitian-tailored Nutrition Intervention to Patients With Critical Illness (DETAIL)

The Effect of a 6-month DiEtitian-TAILored Nutrition Intervention Compared to Usual Care in Patients With Critical Illness. A Single Center Prospective Intervention Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07149246
Acronym
DETAIL
Enrollment
300
Registered
2025-08-29
Start date
2025-09-01
Completion date
2028-03-31
Last updated
2025-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, ICU Patients, Nutrition Intake

Keywords

Nutrition, Energy intake, Protein intake, ICU, Dietitian

Brief summary

This research project aims to study the effect of optimal and individualised nutrition to patients with critical illness during the intensive care unit (ICU) and hospital admission, and until six months after admission. The investigators want to describe and compare the usual care with a dietitian-tailored nutrition care. The hypothesis is that dietitian-tailored nutrition care will result in a higher mean energy intake compared to usual care.

Detailed description

The study will recruit patients with critical illness in one of two groups. Group one will receive standard nutrition care following the current local guidelines. Group two will receive frequent follow-up by a clinical dietitian from inclusion and until six months from admission. The dietitian will be responsible for the nutrition administered to the patient during hospital admission and will have consultations with the patients after discharge. The patients in group two will receive individualized nutrition care and recommendations. In addition to outcome measures regarding nutrition, the patients can choose if they want to perform physical tests and blood tests as well, but that part of the study is optional. In both groups, outcome measures will be collected at day ten, 30, 90 and 180 days after admission to the ICU. The collection of data will occur even though the patients have been discharged from the hospital, either to their home or another health care facility. The aim is to study the effect of optimal and individualised nutrition to patients with critical illness during the ICU and hospital admission, and until six months after admission. Firstly, the investigators want to describe the usual care and progression of the patients during the first six months after hospital admission. Secondly, the investigators want to see if frequent follow-up by a clinical dietitian can increase nutritional intake during the same period. The hypothesis is that dietitian-tailored nutrition care will result in a higher mean energy intake compared to usual care, and that this will further impact other aspects, such as quality of life and physical function.

Interventions

OTHERNutrition intervention

Frequent follow-up from a dietitian during ICU and hospital stay, and after discharge, up to 6 months after ICU admission.

Sponsors

The Northern Norway Health Authority
CollaboratorUNKNOWN
Karolinska University Hospital
CollaboratorOTHER
University Hospital of North Norway
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

2 arms

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients in intensive care who gives an informed consent and meet all of the following will be eligible: 1. Admitted to the intensive care unit for \>48 hours. 2. At least 18 years of age 3. Have one or more organ system failure (respiratory,cardiovascular or renal) related to their acute illness defined as: a. PaO2/FiO2≤300 mm Hg) b. Currently on one or more continuous inotrope/vasopressor infusion which were started at least 4 hours ago at a minimum dose of: i. Norepinephrine≥0.1 mcg/kg/min ii. Epinephrine≥0.1 mcg/kg/min iii. Any dose of vasopressin iv. Milrinone\>0.1 mcg/kg/min) c. Renal dysfunction defined as: i. Serum creatinine 2.0-2.9 times baseline or ii. Urine output 0.5 mL/kg/hour for ≥12 hours or iii. Currently receiving renal replacement therapy) d. Currently has an intracranial pressure monitor or ventricular drain in situ 4. Permanent living address in Norway

Exclusion criteria

Patients will be excluded if: 1. Death is imminent in the next 96 hours or there is a current treatment limitation in place or the patient is unlikely to survive to 180 days due to underlying/chronic illness 2. Dialysis dependent chronic renal failure 3. Suspected or known pregnancy 4. Wheelchair user 5. Cognitive impairment in which intervention is considered not appropriate 6. Eating disorders -

Design outcomes

Primary

MeasureTime frameDescription
Mean energy intakeUp to 6 monthsMean energy intake from day 10 to the end of follow-up of 6 months.

Secondary

MeasureTime frameDescription
Health related quality of lifeDay 10, day 30, day 90 and day 180Assessed using the European Quality Of Life 5 Dimensions (EQ-5D) descriptive system. Each dimension has 5 levels ranging from no problems (1) to extreme problems (5), there is no overall score.
MobilityICU admission up to 6 monthsAssessed during intensive care unit (ICU) admission using the 11-category ICU Mobility Scale, with 10 as the maximum value, where 0 indicate no activity and 10 indicate independent walking.
WeightBaseline, day 10, day 30, day 90 and day 180Weight, Changes in weight between measurement points
Physical performanceDay 10, day 30, day 90 and day 180Changes in physical performance will be assessed using the Short Physical Performance Battery (SPPB). It consists of three tests; gait speed, balance test and a sit-to-stand test. The scores of the three tests are summarized, and the total score is ranging from 0 points to a maximum of 12 points. The score is divided in three levels of performance: low (0-6 points), medium (7-9 points), and high (10-12 points)
Hand grip strengthDay 10, day 30, day 90 and day 180Changes in hand grip strength assessed with a hand dynamometer
Body compositionDay 10, day 30, day 90 and day 180Changes in fat-free mass and lean mass assessed with bioelectrical impedance analysis (BIA).
Muscle massBaseline, day 10, day 30, day 90 and day 180Changes in muscle mass assessed with ultrasound
Resting energy expenditureDay 10, day 30, day 90 and day 180Changes in resting energy expenditure measured with indirect calorimetry
Protein intakeUp to 6 monthsMean protein intake from day 10 to the end of follow-up of 6 months.
Nutrition intakeDay 10, day 30, day 90 and day 180Energy and protein intake on each measurement point, Energy and protein intake by location (intensive care unit and ward), Energy and protein intake delivered by nutrition therapy
Nutrition risk during overall follow-upBaseline, day 10, day 30, day 90 and day 180Assessed with Nutrition Risk Screening 2002 (NRS-2002) at all measure time points, where the score 0-2 indicate no nutrition risk, and a score \> 3 indicate nutrition risk.
Nutrition risk during ICU admissionICU admission up to 6 monthsAssessed with the modified Nutrition Risk in Critically Ill (mNUTRIC) score, ranging from a minimum value of 0 and a maximum value of 9. 0-4 points indicate a low malnutrition risk, 5-9 points indicate patients at high nutrition risk which are the most likely to benefit from aggressive nutrition therapy.
Self-rated health stateDay 10, day 30, day 90 and day 180Self-rated by the participants using the European Quality Of Life Visual Analogue Scale (EQ-VAS). The VAS ranges from The worst health you can imagine (0) to The best health you can imagine (100).
FrailtyBaseline, day 10, day 30, day 90 and day 180Assessed with clinical frailty scale (CFS), which is an ordinal scale with nine steps from very fit (1) to terminally ill (9).

Other

MeasureTime frameDescription
MortalityUp to 6 monthsIntensive care unit (ICU), in hospital and 30-day, 90-day and 6 months mortality
Effect of energy intake above 20 kcal/kg/dagDay 10, day 30, day 90 and day 180Independent of group allocation, an analysis regarding all secondary outcome measures will be performed comparing participants with an energy intake of \>20 kcal/kg/day with participants with \<20 kcal/kg/day
Effect of energy intake above 25 kcal/kg/dayDay 10, day 30, day 90 and day 180Independent of group allocation, two analysis regarding all secondary outcome measures will be performed comparing participants with an energy intake of \>25 kcal/kg/day with participants with \<25 kcal/kg/day.
Cost per quality-adjusted life year6 monthsCost per quality-adjusted life year (QALY)
Cost per life-year gained6 monthsCost per life-year gained (LYG)
ICU stayUp to 6 monthsDuration of intensive care unit (ICU) stay in survivors and non-survivors
Hospital stayUp to 6 monthsDuration of hospital stay in survivors and non-survivors

Countries

Norway

Contacts

Primary ContactAnders Benjamin Kildal, MD, PHD
anders.benjamin.kildal@unn.no+47 77798928
Backup ContactTuva Hjetland Løland, MSNC
tuva.hjetland.loland@unn.no+4777626385

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026